FairJourney Biologics
Who owns FairJourney Biologics?
FairJourney Biologics is a Portuguese Biotech company, currently owned by Partners Group since 2024. It changed hands in 2024, when GHO Capital sold.
Hand-verified · updated 2026-07-07
Open JSON · CC-BYKey facts
Ownership history
2 ownership periods
GHO Capital sold FairJourney Biologics to Partners Group in 2024 after 4 years.
More from Partners Group Direct Equity V
Other portfolio companies in the same fund.
More Partners Group portfolio companies
From the same investor, across funds.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns FairJourney Biologics?
FairJourney Biologics is currently owned by Partners Group, through Partners Group Direct Equity V, since 2024.
When did Partners Group acquire FairJourney Biologics?
Partners Group acquired FairJourney Biologics in 2024.
Who did FairJourney Biologics sell to?
GHO Capital sold FairJourney Biologics to Partners Group in 2024 (Secondary).
Who has owned FairJourney Biologics over time?
FairJourney Biologics has been through 2 private-equity ownership periods: GHO Capital · via GHO Capital Fund II LP · 2020–2024 · sold to Partners Group · (Secondary); Partners Group · via Partners Group Direct Equity V · since 2024.